ERBB2 and breast carcinoma: The classification of breast cancer based on the coding region identified potential genetic targets including the CCND1 gene, which is amplified in 30 to 58% of breast cancers; the estrogen receptor (ERα); and/or progesterone receptor (PR) and Her2.